These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
137 related articles for article (PubMed ID: 16002183)
1. Antimicrobial susceptibility of polymerase chain reaction ribotypes of Clostridium difficile commonly isolated from symptomatic hospital patients in the UK. John R; Brazier JS J Hosp Infect; 2005 Sep; 61(1):11-4. PubMed ID: 16002183 [TBL] [Abstract][Full Text] [Related]
2. Clostridium difficile infections in a Shanghai hospital: antimicrobial resistance, toxin profiles and ribotypes. Huang H; Wu S; Wang M; Zhang Y; Fang H; Palmgren AC; Weintraub A; Nord CE Int J Antimicrob Agents; 2009 Apr; 33(4):339-42. PubMed ID: 19097757 [TBL] [Abstract][Full Text] [Related]
3. Antimicrobial susceptibility patterns of Clostridium difficile strains belonging to different polymerase chain reaction ribotypes isolated in Poland in 2012. Lachowicz D; Pituch H; Obuch-Woszczatyński P Anaerobe; 2015 Feb; 31():37-41. PubMed ID: 25242196 [TBL] [Abstract][Full Text] [Related]
4. The epidemiology of Clostridium difficile in Scotland. Wiuff C; Brown DJ; Mather H; Banks AL; Eastaway A; Coia JE J Infect; 2011 Apr; 62(4):271-9. PubMed ID: 21300104 [TBL] [Abstract][Full Text] [Related]
5. [Epidemiological study of Clostridium difficile strains isolated in Jean-Verdier-René-Muret hospitals from 2001 to 2007]. Poilane I; Fantinato C; Cruaud P; Collignon A Pathol Biol (Paris); 2008; 56(7-8):412-6. PubMed ID: 18842360 [TBL] [Abstract][Full Text] [Related]
6. Association between PCR ribotypes and antimicrobial susceptibility among Clostridium difficile isolates from healthcare-associated infections in South Korea. Kim J; Kang JO; Pai H; Choi TY Int J Antimicrob Agents; 2012 Jul; 40(1):24-9. PubMed ID: 22578765 [TBL] [Abstract][Full Text] [Related]
8. Control of an outbreak of diarrhoea in a vascular surgery unit caused by a high-level clindamycin-resistant Clostridium difficile PCR ribotype 106. Ratnayake L; McEwen J; Henderson N; Nathwani D; Phillips G; Brown D; Coia J J Hosp Infect; 2011 Nov; 79(3):242-7. PubMed ID: 21864938 [TBL] [Abstract][Full Text] [Related]
9. Distinct ribotypes and rates of antimicrobial drug resistance in Clostridium difficile from Shanghai and Stockholm. Huang H; Fang H; Weintraub A; Nord CE Clin Microbiol Infect; 2009 Dec; 15(12):1170-3. PubMed ID: 19624517 [TBL] [Abstract][Full Text] [Related]
10. Surveillance of antibiotic resistance among common Clostridium difficile ribotypes in Hong Kong. Chow VCY; Kwong TNY; So EWM; Ho YII; Wong SH; Lai RWM; Chan RCY Sci Rep; 2017 Dec; 7(1):17218. PubMed ID: 29222426 [TBL] [Abstract][Full Text] [Related]
12. Antimicrobial susceptibility and heteroresistance in Chinese Clostridium difficile strains. Huang H; Weintraub A; Fang H; Wu S; Zhang Y; Nord CE Anaerobe; 2010 Dec; 16(6):633-5. PubMed ID: 20849968 [TBL] [Abstract][Full Text] [Related]
13. Predominance of Clostridium difficile ribotypes 012, 027 and 046 in a university hospital in Chile, 2012. Plaza-Garrido Á; Barra-Carrasco J; Macias JH; Carman R; Fawley WN; Wilcox MH; Hernández-Rocha C; Guzmán-Durán AM; Alvarez-Lobos M; Paredes-Sabja D Epidemiol Infect; 2016 Apr; 144(5):976-9. PubMed ID: 26489717 [TBL] [Abstract][Full Text] [Related]
14. PCR ribotype prevalence and molecular basis of macrolide-lincosamide-streptogramin B (MLSB) and fluoroquinolone resistance in Irish clinical Clostridium difficile isolates. Solomon K; Fanning S; McDermott S; Murray S; Scott L; Martin A; Skally M; Burns K; Kuijper E; Fitzpatrick F; Fenelon L; Kyne L J Antimicrob Chemother; 2011 Sep; 66(9):1976-82. PubMed ID: 21712239 [TBL] [Abstract][Full Text] [Related]
15. Surveillance of Antibiotic Resistance among Hospital- and Community-Acquired Toxigenic Clostridium difficile Isolates over 5-Year Period in Kuwait. Jamal WY; Rotimi VO PLoS One; 2016; 11(8):e0161411. PubMed ID: 27536994 [TBL] [Abstract][Full Text] [Related]
16. [Survey of susceptibility of clinical Clostridium diffiicile strains isolated from patients hospitalised in different departments of paediatric hospital to antimicrobial agents]. Wultańska D; Obuch-Woszczatyński P; Pituch H; Luczak M Med Dosw Mikrobiol; 2007; 59(2):161-8. PubMed ID: 17929413 [TBL] [Abstract][Full Text] [Related]
17. Change in antimicrobial susceptibility and PCR ribotypes of Clostridioides difficile in a hospital over 5 years: Correlation analysis with antimicrobial consumption. Seo MR; Kim B; Kim J; Pai H Int J Antimicrob Agents; 2019 Aug; 54(2):154-158. PubMed ID: 31173866 [TBL] [Abstract][Full Text] [Related]
18. [Antimicrobial susceptibility of Clostridium difficile clinical isolates collected from 2001 to 2007 in a French university hospital]. Cattoir V; Ould-Hocine ZF; Legrand P Pathol Biol (Paris); 2008; 56(7-8):407-11. PubMed ID: 18845403 [TBL] [Abstract][Full Text] [Related]
19. Changes in antibiotic susceptibility and ribotypes in Clostridium difficile isolates from southern Scotland, 1979-2004. Taori SK; Hall V; Poxton IR J Med Microbiol; 2010 Mar; 59(Pt 3):338-344. PubMed ID: 19942691 [TBL] [Abstract][Full Text] [Related]
20. Antimicrobial activity of LFF571 and three treatment agents against Clostridium difficile isolates collected for a pan-European survey in 2008: clinical and therapeutic implications. Debast SB; Bauer MP; Sanders IM; Wilcox MH; Kuijper EJ; J Antimicrob Chemother; 2013 Jun; 68(6):1305-11. PubMed ID: 23420839 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]